Cellular Origins

Don't miss this fantastic interview at @staubligroup's Pharma Impulses meets #ACHEMA24! Dan Strange & Leo Steenson discuss how Cellular Origins is transforming patient access to #celltherapy by enabling scalable, cost- and space-efficient manufacture. ➡bit.ly/45xbAsM

The vast progress in this space highlights the need for cost-effective, high throughput manufacturing processes. Robotic, automated systems like Constellation™ will play a pivotal role in bringing these life-saving therapies to patients. Read more: bit.ly/3WnN8Gm

The recent Hanson Wade Intelligence June Report discusses how CAR #celltherapies are revolutionising the autoimmune disease (AID) sector. There are currently 107 therapeutic candidates within this space 🟡54 are in a preclinical setting 🟡53 have entered #clinicaltrials

The vast progress in this space highlights the need for cost-effective, high throughput manufacturing processes. Robotic, automated systems like Constellation™ will play a pivotal role in bringing these life-saving therapies to patients. Read more: bit.ly/3WnN8Gm

Read more about CAR T cell therapies and autoimmune Disease ⬇ BMJ Journals: bit.ly/3SlDVgh Nature Reviews Immunology: bit.ly/3SlwiGJ

Jason Jones, Global BD Lead: "Success for these patients relies on our ability to produce upwards of hundreds of thousands of these engineered cells. [...] robotics and full, inclusive automation could be the only way to produce these therapies at anywhere near those numbers."

What's next for CAR T? The race to the first blockbuster therapy - Could it be in Autoimmune Disease? These two reviews discuss the use of Chimeric antigen receptor (CAR) T cell therapy for autoimmune disease (AID), which affects 10% of the population.

Apply now to join our team, and play a crucial role in the development of an elegant, next-generation solution to transform patient access to life-saving #celltherapies: bit.ly/45MiVF4

We are #hiring for a Simulation Lead. We are seeking someone with a real-world problem-solving mindset and a deep expertise in simulation. As part of our team, you’ll play a pivotal role in designing and developing our robotic Constellation™ system.

Meet Nikki Phoolchund, our Reliability & Test Lead. Previously at CMR Surgical, she designed several components for the robotic surgical arm, taking it from early concept to testing for regulatory approval. Career opportunities at Cellular Origins ➡ rb.gy/d8bubq

Find out more about the Women in Advanced Therapies community and their events here: bit.ly/4f5CRaf

Last week, Jason Jones took part in a panel at @Phacilitate's Women in Advanced Therapies Global event. The session explored the intricacies of different communication styles, and how they hold the key to building effective connections in an increasingly diverse world.

Does this sound like you? Apply to join our team, and help us lead the revolution to transform how we tackle the challenges of #celltherapy production: bit.ly/3L5GeAi

We’re #hiring for a Head of Manufacturing. We are seeking a highly experienced, innovative and delivery-focused manufacturing leader to join our senior leadership team, collaborating closely with several partners and teams to drive our manufacturing efforts.

We've been shortlisted in this year's #BusinessWeeklyAwards! We're proud to have been recognised alongside other trailblazing companies from across #Cambridgeshire that are leading the way in #lifesciences, #tech, #engineering & more. Full shortlist: bit.ly/4bA8QfK

We're still looking for talented individuals from engineering & other disciplines to join our team and help develop our cutting-edge robotic system, Constellation™. If you're excited about our mission, we'd love to hear from you. Express your interest ➡ bit.ly/3WiMoU3

It’s been an incredibly exciting first 6 months of 2024 for Cellular Origins. The best thing? The growth of the exceptional team. Since we began in 2023, we've expanded rapidly to help drive us forward on our mission to transform patient access to life-saving #celltherapies.

We're pleased to announce the appointment of Geoffrey Hodge as Non-Executive Director, further strengthening our Board with significant commercial, strategic and technical experience. Read the full press release here: bit.ly/3LhHpMO

Did you catch our talk at #ACHEMA24? Dr Dan Strange and Dr Leo Steenson were pleased to take part in @staubligroup's Pharma Impulses, a series of interviews with pioneering companies bringing #robotics and #automation into #pharma. Watch here ➡ bit.ly/45xbAsM

#ACHEMA24 was an exciting opportunity to showcase our #robotic platform for scalable manufacture of #cellandgenetherapies, Constellation™. If you would like to learn about how we can work together, please get in touch 📧 hello@cellularorigins.com